J B Chemicals Pharmaceuticals Ltd vs Jenburkt Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 19, 2026

Key Highlights

The Latest Trading Price of J B Chemicals & Pharmaceuticals Ltd is ₹ 2168 as of 19 May 12:00 . The P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 21.6 on March 2021 to 38.3 on March 2025 . This represents a CAGR of 12.14% over 5 yearsThe P/E Ratio of Jenburkt Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 9688 crore on March 2021 to ₹ 25253 crore on March 2025 . This represents a CAGR of 21.12% over 5 yearsThe Market Cap of Jenburkt Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of J B Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 916.21 crore as compare to the Dec '25 revenue of ₹ 1083 crore. This represent the decline of -15.4% The revenue of Jenburkt Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 185.93 crore as compare to the Dec '25 ebitda of ₹ 314.1 crore. This represent the decline of -40.81% The ebitda of Jenburkt Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 176.83 crore to ₹ 101.37 crore over 8 quarters. This represents a CAGR of -24.29% The net profit of Jenburkt Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 28.53 % on March 2021 to 36.98 % on March 2025 . This represents a CAGR of 5.33% over 5 yearsThe Dividend Payout of Jenburkt Pharmaceuticals Ltd changed from 28.37 % on March 2021 to 24.76 % on March 2025 . This represents a CAGR of -2.69% over 5 years .

About J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family.
The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries.
It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe.
The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements.

FAQs for the comparison of J B Chemicals & Pharmaceuticals Ltd and Jenburkt Pharmaceuticals Ltd

Which company has a larger market capitalization, J B Chemicals & Pharmaceuticals Ltd or Jenburkt Pharmaceuticals Ltd?

Market cap of J B Chemicals & Pharmaceuticals Ltd is 34,116 Cr while Market cap of Jenburkt Pharmaceuticals Ltd is 522 Cr

What are the key factors driving the stock performance of J B Chemicals & Pharmaceuticals Ltd and Jenburkt Pharmaceuticals Ltd?

The stock performance of J B Chemicals & Pharmaceuticals Ltd and Jenburkt Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for J B Chemicals & Pharmaceuticals Ltd and Jenburkt Pharmaceuticals Ltd?

As of May 19, 2026, the J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹2124.85. On the other hand, Jenburkt Pharmaceuticals Ltd stock price is INR ₹1183.6.

How do dividend payouts of J B Chemicals & Pharmaceuticals Ltd and Jenburkt Pharmaceuticals Ltd compare?

To compare the dividend payouts of J B Chemicals & Pharmaceuticals Ltd and Jenburkt Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.